A Research Study on How Semaglutide Works in People With Fatty Liver Disease and Liver Damage
Condition: Non-alcoholic Steatohepatitis Interventions: Drug: Semaglutide; Drug: Placebo (semaglutide) Sponsor: Novo Nordisk A/S Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Fatty Liver Disease (FLD) | Liver | Liver Disease | Research | Study | Urology & Nephrology